Results
1 -
10 of
107Alison C. Donnelly, Huiping Zhao, Bhaskar Reddy Kusuma and Brian S. J. Blagg.
Cytotoxic sugar analogues of an optimized novobiocin scaffold, Med. Chem. Commun., 2010, 1, 165. Degterev et al..
Identification of RIP1 kinase as a specific cellular target of necrostatins, Nature Chemical Biology, 2008 Rodnina et al..
Selective compounds define Hsp90 as a major inhibitor of apoptosis in small cell lung cancer, Nature Chemical Biology, 2007 Eichner Simone.
New, Highly Active Nonbenzoquinone Geldanamycin Derivatives by Using Mutasynthesis, ChemBioChem, 2009 Jared T. Shaw.
Naturally diverse: highlights in versatile synthetic methods enabling target- and diversity-oriented synthesis, Nat. Prod. Rep., 2009, 26, 11. Da-Woon JungThese authors contributed equally to this work., Eun-Sang Oh, Si-Hwan Park, Young-Tae Chang, Cheol-Hee Kim, Seok-Yong Choi and Darren R. Williams.
A novel zebrafish human tumor xenograft model validated for anti-cancer drug screening, Mol. Biosyst., 2012, 8, 1930. Vincenza Barresi, Cosimo G. Fortuna, Roberta Garozzo, Giuseppe Musumarra, Salvatore Scirè and Daniele F. Condorelli.
Identification of genes involved in the sensitivity to antitumour drug 17-allylamino,17-demethoxygeldanamycin (17AAG), Mol. Biosyst., 2006, 2, 231. Marcos H. Woehrmann, Walter M. Bray, James K. Durbin, Sean C. Nisam, Alicia K. Michael, Emerson Glassey, Joshua M. Stuart and R. Scott Lokey.
Large-scale cytological profiling for functional analysis of bioactive compounds, Mol. Biosyst., 2013, .